| 17β-HSD1 | 17β-hydroxysteroid dehydrogenase 1 |
| AF-1 and AF-2 | activation functions -1 and -2 |
| AMF | autocrine motility factor |
| BORIS | brother of regulator of imprinted sites |
| CAF | cancer-associated fibroblast |
| CC | cervical cancer |
| ceRNA | competing endogenous RNA |
| DBD | DNA-binding domain |
| DNMT | DNA methyltransferase |
| E1 | estrone |
| E2 | 17β-estradiol |
| E3 | estriol |
| E4 | estetrol |
| EC | endometrial cancer |
| EMT | epithelial-to-mesenchymal transition |
| ER α/β | estrogen receptor alpha/beta |
| ERE | estrogen response element |
| FSH | follicle-stimulating hormone |
| GnRH | gonadotropin-releasing hormone |
| GPER1 | G protein-coupled estrogen receptor 1 |
| HDAC | histone deacetylase |
| HMGA2 | high-mobility-group A2 protein |
| HPO | hypothalamic–pituitary–ovarian |
| HPV | human papillomavirus |
| IHC | immunohistochemistry |
| InsR | insulin receptor |
| LBD | ligand binding domain |
| LH | luteinizing hormone |
| MMP | metalloprotease |
| OC | ovarian cancer |
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
| PgR | progesterone receptor |
| SIX1 | sine oculis-related homeobox 1 homologue |